Results 81 to 90 of about 2,137,881 (310)

Cognitive impairment profile in patients with the m.3243A> G variant in mitochondrial DNA

BMC Neurology
Background The m.3243A>G variant in mitochondrial DNA is associated with a wide spectrum of clinical features ranging from asymptomatic subjects to severely symptomatic patients. Cognitive involvement is one of the clinical features, but its severity and
Satu Winqvist, Mikko Kärppä, Jukka S. Moilanen, Kari Majamaa   +3 more
doaj   +1 more source

Kaplan-Meier estimate of percentage of recurrent stroke.

, 2014
Kaplan-Meier estimate of percentage of recurrent stroke.
Yuen-Kwun Wong (521825), Kay-Cheong Teo (521826), Richard Shek-Kwan Chang (521827), Sonny Fong-Kwong Hon (521828), Shu-Leong Ho (101984), Raymond Tak-Fai Cheung (521829), Koon-Ho Chan (291734), Hung-Fat Tse (351982), Kui-Kai Lau (521824), Leonard Sheung-Wai Li (521830), Chung-Wah Siu (351983)   +10 more
core   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

Molecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic, Rafael Stroggilos, Mladen Marinkovic, Ana Djuric, Suzana Stojanovic‐Rundic, Radmila Jankovic, Sergi Castellvi‐Bel, Remond J.A. Fijneman, Antonia Vlahou, Jerome Zoidakis, Milena Cavic   +10 more
wiley   +1 more source

Breast Cancer–Specific Survival and Prognostic Factors in a Statewide Oncology Network in Brazil: A Registry‐Linked Retrospective Cohort Study

Cancer Reports
Background Breast cancer survival varies widely across middle‐income settings and may be influenced by clinical stage at diagnosis and access pathways within oncology care networks.
Raphael Manhães Pessanha, Wesley Rocha Grippa, Luiz Cláudio Barreto Silva Neto, Naira Santos D'Agostini, Luís Carlos Lopes‐Júnior   +4 more
doaj   +1 more source

Are competing risks models appropriate to describe implant failure?

Acta Orthopaedica, 2018
Background and purpose — The use of competing risks models is widely advocated in the arthroplasty literature due to a perceived bias in comparison of simple Kaplan–Meier estimates.
Adrian Sayers, Jonathan T Evans, Michael R Whitehouse, Ashley W Blom   +3 more
doaj   +1 more source

Kaplan-Meier estimate survival curves showing unfavorable treatment outcome of new PTB patients by total delay status.

, 2016
Kaplan-Meier estimate survival curves showing unfavorable treatment outcome of new PTB patients by total delay status.
Senedu Bekele Gebreegziabher (3148827), Gunnar Aksel Bjune (848412), Solomon Abebe Yimer (848413)   +2 more
core   +1 more source

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

Molecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen, Zhi Zhao, Henrik Horndalsveen, Maria Moksnes Bjaanæs, Bjørn Henning Grønberg, Tarje Halvorsen, Tesfaye Madebo, Marianne Aanerud, Jussi Koivunen, Kersti Oselin, Saulius Cicenas, Nina Helbekkmo, Jarkko Ahvonen, Maria Silvoniemi, Tine Norman Alver, Tonje Dalen, Åsa Kristina Öjlert, Saima Jamil Farooqi, Åslaug Helland, Vilde Drageset Haakensen   +19 more
wiley   +1 more source

Maximum disease diameter is associated with outcomes in stage II follicular lymphoma treated with radiation therapy alone

Clinical and Translational Radiation Oncology
Purpose: The optimal management of stage II follicular lymphoma (FL) is unclear. Radiation therapy (RT) alone has been the gold standard treatment, but a proportion of patients relapse.
Yi Xu, Belinda A. Campbell, Matthew Chan, Jessica Chan, Pedro Farinha, Christopher P. Venner, David W. Scott, Alina S. Gerrie, Diego Villa, Laurie H. Sehn, Kerry J. Savage, Andrea C. Lo   +11 more
doaj   +1 more source

Kaplan-Meier survival graph grouped by percutaneous treatment: X-axis = survival in months; Y-axis = survival estimate.

, 2020
Kaplan-Meier survival graph grouped by percutaneous treatment: X-axis = survival in months; Y-axis = survival estimate.
Riccardo Muglia (8298909), Isabella Bolengo (8298912), Roberto Ceriani (8298921), Ezio Lanza (8298906), Dario Poretti (8298915), Felice D’Antuono (8298918), Vittorio Pedicini (8298927), Guido Torzilli (8298924)   +7 more
core   +1 more source

Kaplan-Meier survival analysis.

, 2022
a. Kaplan-Meier survival analysis of the “any time before” analysis. b. Kaplan-Meier survival analysis of the “within 72h” analysis.
Masamitsu Sanui (3452669), Junji Shiotsuka (4277068), Shigehiko Uchino (2305), Alan Kawarai Lefor (6593720), Tomoyuki Masuyama (12380784), Yusuke Sasabuchi (5052107)   +5 more
core   +1 more source